345 Park Avenue South

Mega Menu WP The Core Labs Behind the Deals - Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Apply for Membership

Where Healthcare Innovators Connect

Magenta

Events

Accelerating Advances in Health

Green

About

Contact Us

# About
Megan Eileen McDonough is an award-winning journalist who covers travel, tech, health, AI, and thought leadership. 

## Experience
McDonough is a seasoned writer and content strategist with a background in travel, wellness, health, and personal development. Her work has appeared in outlets such as *Lonely Planet*, *AFAR*, *Fodor’s*, *Spotify*, and *Success Magazine*, among others. McDonough has interviewed founders, psychologists, wellness practitioners, and creatives from around the world. With a keen eye for nuance and a strong sense of voice, she shares stories that connect with readers on a personal level. You can learn more about McDonough’s work as a content strategist here and explore her writing portfolio [here](https://www.meganeileen.com/).

### Education
McDonough earned a BS in psychology and a BA in English from the University of Mary Washington. 


Contributing Writer

Philadelphia is where modern cell and gene therapy was born, and the field is still concentrated there. Here are seven companies driving the region's life sciences scene, from gene therapy to obesity drugs.

7 Major Biotech Companies in Philadelphia

Pfizer, Lilly, and Bristol Myers Squibb have spent tens of billions buying into radiopharmaceuticals. Here are 10 companies still building on their own, and what makes them worth acquiring.

Radiopharmaceutical Thumbnail

10 Biotech Companies Advancing Radiopharmaceutical Treatments

The bar for Series A keeps rising, but these firms are still funding early biotech—and they’re the ones founders should have on their radar.

260805_Series_A_investment_incubator_vc 16x9

10 VCs Writing Biotech Series A Checks in 2026

Accelerators and incubators can provide far more than funding — they offer mentorship, lab resources, investor connections, and founder communities. This guide provides an overview of 12 of the top programs in the U.S. helping startups navigate the path to commercialization.

260806 accelerator_rocket_speed_launch 16x9

12 Biotech Accelerators That Actually Move the Needle for Founders

Venture capital is flooding into menopause, just not into the provider training and clinical access that could make a real difference for patient and their care providers.

Menopause funding piece - Image

Is the Menopause Investment Boom Missing the Point?

The latest AI drug discovery venture capital news, updated monthly—tracking funding rounds of $10M or more in 2026.

Cure’s AI Drug Discovery Funding Tracker 2026

From gene therapy to AI-driven target discovery, these eight firms are actively writing checks in rare disease biotech.

8 VCs Funding Rare Disease Startups in 2026

From early-stage senolytics to AI-driven drug discovery, these seven firms are actively writing checks in longevity biotech.

VCs Funding Longevity and Anti-Aging Startups In 2026 - Image

VCs Funding Longevity and Anti-Aging Startups In 2026 - Image 02

7 VCs Funding Longevity Startups in 2026

The startup is using insights from the Cure by Deerfield Middle East Health Accelerator to refine its care model and expand access to pediatric endocrinology across new markets.

Virginia-Based EndoMD Builds Momentum After Third-Place Finish in Cure Accelerator

After placing second at the Cure by Deerfield Middle East Health Accelerator in Qatar, NYC-based biotech VentriNaya is advancing its regenerative gene and cell therapy programs for cardiovascular disease while preparing for fundraising and regulatory milestones.

NYC-Based Gene and Cell Therapy Startup Builds Momentum After Runner-Up Finish in Cure Accelerator

After taking first place at The Cure by Deerfield Middle East Health Accelerator’s Demo Day, Atomistic Insights is establishing a presence in Qatar and exploring co-discovery partnerships, as it advances its physics-driven AI platform for drug development.

After Accelerator Win, Atlanta-Based AI Drug Discovery Startup Eyes Growth in Qatar

Explore North Carolina’s most impactful biotech and life sciences companies, and learn why the state's Research Triangle Park (RTP), in particular, continues to be one of the nation’s leading hubs for biopharma investment and growth.

12 Biggest Biotech and Life Science Companies in North Carolina’s Research Triangle

Explore the biggest biotech companies in the San Francisco Bay Area and see how the region’s mix of top research institutions, venture capital, and AI expertise keeps it at the center of global life sciences, even amid funding pressure and market recalibration.

11 Biggest Biotech Companies in the Bay Area

From AI-native care models to regulatory whiplash and new pressures around coverage and privacy, Out-of-Pocket Health founder Nikhil Krishnan lays out the forces expected to reshape biotech in the year ahead.

5 Ways Biotech Will Change in 2026, According to Nikhil Krishnan

Three biotech and digital health startups emerged as winners of Cure’s MEHA Demo Day, reflecting the region’s growing healthcare innovation ecosystem.

Cure’s Middle East Health Accelerator Picks Three Startups with Potential to Scale in the Region

Explore the biggest and most groundbreaking biotech companies in San Diego, and discover why the region remains one of the most vibrant life science hubs in the US.

11 Biggest Biotech Companies in San Diego

These biotech internship programs offer hands-on experience, mentorship, and real exposure to the U.S. life sciences ecosystem.

5 Notable Biotech Internships for Students and Recent Grads

From fundraising and company building to regulation and market shifts, these biotech podcasts offer practical insights to keep you in the know.

10 Must-Listen Biotech Podcasts for Founders, Investors, and Operators

Brianne Kimmel is redefining how women’s health gets funded. As founder and managing partner of WorkLife Ventures, she invests in female-led startups focused on making care more accessible, affordable, and aligned with women’s real-life needs.

Brianne Kimmel on Backing Female Founders Reshaping Women’s Health

A practical guide for biotech founders on how to navigate the investor Q&A with clarity and confidence. Learn how to prepare, show traction, communicate your why, and present a plan investors can trust.

The Investor Q&A Is Crucial to Your Biotech Pitch—Here’s How to Nail It

AI tools now shape how investors, partners, and the public evaluate healthcare startups. Digital strategy leader Paul Herbert explains how AI interprets credibility and what founders can do to strengthen their visibility and trust signals.

SEO 2.0: How AI Shapes the Perception of Your Healthcare Startup

Explore the biggest biotech companies in Boston and Cambridge, their commercial pipelines, and why this life-science cluster remains the nation’s top center for innovation and investment.

13 Biggest Biotech Companies In Boston 

From funding wins to pipeline breakthroughs, these companies are the key players on New York's booming biotech scene.

New York Biotech Companies Hero Image

13 Biggest Biotech Companies in New York

Due diligence decks are a key step for healthcare startups seeking investment, giving investors a clear view of clinical, regulatory, and financial risks. This guide breaks down what to include in your deck and how to effectively communicate your company’s value.

How to Build a Winning Due Diligence Deck for Your Healthcare Startup

Milestone-based financing can be an effective way for investors to manage risk and for founders to complete successful clinical trials and gain regulatory approval. Here's what biotech entrepreneurs need to know before seeking this type of funding. 

The Pros and Cons of Milestone-Based Financing for Biotech Startups

Experts advise focusing on three main factors that can help founders refine their message, highlight market fit, and ultimately secure funding. 

Tips for Building a Healthcare Pitch Deck That Wins Over Investors

In the competitive world of consumer health, even the best product can fail without the right revenue strategy. Entrepreneurs share lessons on five proven B2C models and how to align them with user needs, trust, and compliance.

5 Proven B2C Revenue Models for Healthcare Startups

Accelerators and incubators both offer mentorship, resources, and investor access, but their structures, timelines, and risks vary. Here’s what healthcare entrepreneurs need to know to choose what’s best for their startup.

Accelerator vs. Incubator: Which is Right for Your Healthcare Startup?

Chat GPT-5 offers faster reasoning, multimedia support, and scalable efficiency that create opportunities for healthcare companies to boost productivity, improve health literacy, and expand access to underserved populations.

What Chat GPT-5 Means for Healthcare Startups and Providers

Crowdfunding can offer mission-driven healthcare startups early traction and autonomy, but founders must navigate investor perceptions, regulatory complexity, and platform tradeoffs.

Should you Crowdfund your Healthcare Startup?

Should You Crowdfund Your Healthcare Startup?

Pitch competitions can boost credibility, sharpen your strategy, and connect you with investors—but they also demand time and focus. Here's how to decide if they’re worth it for your startup.

Should You Enter a Pitch Competition? What Healthcare Startups Need to Know HERO image

Should You Enter a Pitch Competition? What Healthcare Startups Need to Know

OFFOR Health and LOUD Capital founder Navin Goyal, MD, breaks down five proven B2B models, from subscriptions to data licensing, and reveals the biggest mistake healthcare entrepreneurs make when selling to providers and payers.

Cure’s Biotech Funding Tracker 2026

Cure Original Report: The Core Labs Behind the Deals

Your Home in NYC

Where Healthcare Innovators Connect

Accelerating Advances in Health

Megan Eileen McDonough

32 Articles by Megan Eileen McDonough